Q2 2026 Healthcare Realty Trust Inc Earnings Call Transcript
Key Points
- Healthcare Realty Trust Inc (HR) outperformed all key strategic plan objectives over the past four quarters, including 5.7% average same-store NOI growth and nearly 93% same-store occupancy.
- The company raised full-year 2026 normalized FFO per share guidance by $0.02 to $1.64 at the midpoint, driven by strong operations, leasing, and a successful convertible bond offering.
- Executed 3.5 million square feet of leases year-to-date, representing over 10% of the total portfolio, with a weighted average remaining lease term improved by 15 months to 65 months.
- Completed accretive capital allocation, including $200 million in JV acquisitions with KKR at a 7.5% yield to HR, and $75 million in share repurchases at a blended price of $18.50, creating over $30 million in shareholder value.
- Strengthened health system relationships with major deals, including CommonSpirit, Wellstar, and Ascension St. Thomas, featuring positive cash leasing spreads and strategic land sales at premium pricing.
- Redevelopment portfolio leased up to 67%, a 1,400 basis point improvement over four quarters, with underwriting 10% cash-on-cash yields and a strong pipeline for future absorption.
- Successfully addressed near-term debt maturities by raising $1.1 billion at a blended interest rate of approximately 4%, saving 100 basis points versus original guidance and providing ample liquidity through 2029.
- Tenant retention remained strong at 88.5%, with signed-not-occupied leases representing 140 basis points of future occupancy, providing visibility into additional gains in the back half of the year.
- Cash leasing spreads averaged 4.8% in Q2, with average escalators at 3%, and lease IRRs improved nearly 3,000 basis points over the last four quarters.
- The company is the only public REIT actively growing its medical office platform, with a robust leasing pipeline of over 3 million square feet and favorable supply-demand fundamentals.
- Same-store NOI growth decelerated from 6.9% in Q1 to 5.1% in Q2, and the company expects absorption benefits to fade, potentially leading to lower growth rates in the future.
- The company's stock valuation remains below what management believes is justified, and they are not getting credit for their ability to achieve mid-single-digit earnings growth.
- Share repurchases are now less attractive compared to JV acquisitions and redevelopment yields, limiting the potential for immediate accretion from buybacks.
- The company faces ongoing frictional vacancy in its multi-tenant portfolio, which could limit occupancy gains and require continued leasing efforts.
- Disposition guidance increased by $115 million for the year, reflecting the need to fund capital allocation initiatives, which could signal a reliance on asset sales.
- The redevelopment pipeline is expected to peak at around 30 assets by year-end, and the company may not sustain the same level of redevelopment activity beyond the strategic plan period.
- The company's guidance only reflects acquisitions and redevelopments announced to date, leaving uncertainty about future capital allocation and its impact on earnings.
- The transaction market remains competitive, and while the company has a competitive advantage, there is a risk of cap rate expansion if interest rates continue to rise.
- The company's leverage remains in the mid-5 times area, which may limit financial flexibility and increase sensitivity to interest rate movements.
- The company's success is heavily dependent on health system relationships, and any deterioration in these partnerships could negatively impact leasing and growth prospects.
Hello, everyone. Thank you for joining us and welcome to Healthcare Realty's second quarter 2026 earnings call.
(Operator Instructions)
I will now hand the conference over to Doris Lowe. Doris, please go ahead.
Thank you for joining us and welcome to Healthcare Realty's second- quarter 2026 earnings conference call. A reminder that except for the historical information contained within, the matters discussed in this call may contain forward-looking statements that involve estimates, assumptions, risks and uncertainties. These forward-looking statements represent the company's judgment as of the date of this call.
The company disclaims any obligation to update this forward-looking material. A discussion of risks and risk factors are included in our press release and detailed in our filings with the SEC. Certain non-GAAP financial measures will be discussed on this call. A reconciliation of these measures to the most comparable GAAP financial measures may be found in the company's earnings press release for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
